Guillermo Garcia-Manero, MD, on IRAK4, Emavusertib
Guillermo Garcia-Manero, MD, of the Department of Leukemia at MD Anderson Cancer Center, discusses why the novel drug emavusertib, an IRAK4 inhibitor, is a potential treatment option for patients with hematologic malignancies.
670 Madison Ave.
Manalapan, NJ 07726
GU Oncology Now
Cancer Nursing Today
Urban Health Today
© 2022 Mashup Media, LLC. All rights reserved.